Arcus Biosciences, Inc. — Director's Dealing 2021

Apr 26, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arcus Biosciences, Inc. (RCUS)
CIK: 0001724521
Period of Report: 2021-04-23

Reporting Person: KANEKO YASUNORI (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-04-23	Common Stock	P	4133	$31.37	Acquired	7133	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	505050	Indirect
Common Stock	252524	Indirect
Common Stock	131948	Indirect

Footnotes

F1: Shares purchased in a private transaction from Dr. William Grossman, Arcus's Chief Medical Officer.

F2: Thirty-five thousand (35,000) shares previously held directly by the reporting person were transferred to reporting person's trust.

F3: The reporting person's direct ownership includes three thousand (3,000) shares that are Restricted Stock Units that will not vest until June 3, 2021.